Drug Trial Radar · NCT05061732
Helicobacter Pylori Eradication and Follow-up
Last checked: Nov 19, 2026Latest source record: Sep 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4,447
Planned (sponsor's estimate)
Start
Sep 30, 2021
Primary completion
Jun 30, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Shanghai Zhongshan HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 30, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized controlled clinical trial will estimate the eradication efficacy of different therapy for Helicobacter pylori treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.
Conditions
- Helicobacter Pylori Infection
Interventions
RabeprazoleDrug
20mg bid
Bismuth potassium citrateDrug
0.6g bid
MetronidazoleDrug
0.4g qid
ClarithromycinDrug
0.5g bid
LevofloxacinDrug
0.5g qd
AmoxicillinDrug
1g tid
MetronidazoleDrug
0.4g tid
DoxycyclineDrug
0.1g bid
TetracyclineDrug
0.5g qid
Primary outcomes
What the sponsor says the trial is designed to measure.
- Eradication rate of Helicobacter pyloriTime frame: 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.